Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemoradiotherapy versus chemotherapy in locally advanced non-small cell lung cancer
2005-005139-84Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vinorelbine and cisplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Pathological complete response rate (pCR). Started Sep 2006; status: completed.
02
Drugs
vinorelbinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-005139-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005139-84.